
To prospectively assess the safety and functional‐ and oncological outcomes of irreversible electroporation (IRE) as salvage therapy for radio‐recurrent focal prostate cancer in a multicenter setting. Local control was achieved in 29 patients (78%), and 27 patients (73%) were clear of local and systemic disease. Four (11%) patients had local recurrence only. Six (16%) patients developed metastatic disease with a median time to metastasis of 8 months. The FIRE trial shows that salvage IRE after failed radiation therapy for localized PCa is safe with minimal toxicity and promising functional and oncological outcomes. Salvage IRE can offer a solution for notoriously difficult-to-manage radio recurrent prostate tumours.
Like
Save
Share